Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:04 PM
Ignite Modification Date:
2025-12-24 @ 11:04 PM
NCT ID:
NCT07156669
Eligibility Criteria:
Inclusion Criteria:
* Adult patients receiving an ECMO treatment with the Novalung ultimate kit in combination with the Xenios 2.0 (and the MultiSupport Ground during inter- and intra-hospital transport, if applicable) according to the intended use
* Informed consent signed and dated by the attending physician; and
1. If patient is able to give consent: by the study patient
2. If patient is unable to give consent: by the legal representative or
3. If an emergency situation is determined: by a consultant physician
Exclusion Criteria:
* Participation in any interventional clinical study that could impact the results of this prospective, observational PMCF study
* Previous participation in the same study
* ECMO cannulation outside the referring or trial site hospital
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07156669
Study Brief:
Protocol Section:
NCT07156669